title: cDNA microarray analysis of invasive and tumorigenic phenotypes in a breast cancer model.
abstract: The fms oncogene encodes the macrophage colony-stimulating factor receptor (CSF1R), a transmembrane tyrosine kinase receptor, which is abnormally expressed in breast cancer. Transfection of wild-type CSF1R into HC11 mammary epithelial cells (HC11-CSF1R) renders the transfectants capable of in vitro local invasion and in vivo tumorigenesis. Transfection with CSF1R mutated to express phe at the tyr-721 autophosphorylation site (HC11-CSF1R-721) creates a phenotype that lacks metastastic competence but maintains local invasiveness. Conversely, HC11 cells transfected with CSF1R mutated at tyr-807 (HC11-CSF1R-807) retain their metastatic competence, but are not locally invasive. Our aims were to determine which genes were differentially expressed with transfection of HC11 with wild-type CSF1R, and to determine the effect of mutation at the autophosphorylation sites on gene expression, using 4.6 K cDNA microarrays. Complementary DNA from HC11, HC11-CSF1R-721 and HC11-CSF1R-807 were each hybridized together with HC11-CSF1R on individual arrays. A principal component spectral method combined with prenormalization procedures was used for sample clustering. Differentially expressed genes were identified by the analysis of variance. Confirmation by Northern blotting was performed for MAP kinase phosphatase-1, WDNM1 (extracellular proteinase inhibitor), Trop 2 (tumor-associated calcium signal transducer-2), procollagen type IV alpha, secretory leukoprotease inhibitor, prenylated snare protein Ykt6, ceruloplasmin and chaperonin 10. Many of these genes have not previously been associated with tumor invasion and metastasis. We have successfully identified genes that can be linked to the invasive phenotypes or to tumorigenesis. These genes provide a basis for further studies of metastatic progression and local invasiveness, and can be evaluated as therapeutic targets.
authors.affiliation: Department of Medicine, Yale University School of Medicine, New Haven, CT 06520, USA. Harriet.Kluger@Yale.edu
authors.forename: Harriet M
authors.initials: HM
authors.lastname: Kluger
authors.forename: Yuval
authors.initials: Y
authors.lastname: Kluger
authors.forename: Maureen
authors.initials: M
authors.lastname: Gilmore-Hebert
authors.forename: Kyle
authors.initials: K
authors.lastname: DiVito
authors.forename: Joseph T
authors.initials: JT
authors.lastname: Chang
authors.forename: Sofya
authors.initials: S
authors.lastname: Rodov
authors.forename: Olga
authors.initials: O
authors.lastname: Mironenko
authors.forename: Barry M
authors.initials: BM
authors.lastname: Kacinski
authors.forename: Archibald S
authors.initials: AS
authors.lastname: Perkins
authors.forename: Eva
authors.initials: E
authors.lastname: Sapi
mesh_terms: D000818:Animals; D001943:Breast Neoplasms / Q000235:genetics / Q000378:metabolism; D045744:Cell Line, Tumor; D005260:Female; D020869:Gene Expression Profiling; D016236:Genes, fms; D006801:Humans; D007150:Immunohistochemistry; D008325:Mammary Neoplasms, Experimental / Q000235:genetics* / Q000378:metabolism / Q000556:secondary; D051379:Mice; D016297:Mutagenesis, Site-Directed; D009361:Neoplasm Invasiveness / Q000235:genetics; D020411:Oligonucleotide Array Sequence Analysis; D016281:Oncogene Protein gp140(v-fms) / Q000235:genetics / Q000378:metabolism; D010641:Phenotype; D014162:Transfection
chemical_list: D016281:Oncogene Protein gp140(v-fms)